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Abstract
Background: Arsenic is a potent pollutant that has caused an environmental catastrophe in certain parts of the world 
including Bangladesh where millions of people are presently at risk due to drinking water contaminated by arsenic. 
Chronic arsenic exposure has been scientifically shown as a cause for liver damage, cancers, neurological disorders and 
several other ailments. The relationship between plasma cholinesterase (PChE) activity and arsenic exposure has not 
yet been clearly documented. However, decreased PChE activity has been found in patients suffering liver dysfunction, 
heart attack, cancer metastasis and neurotoxicity. Therefore, in this study, we evaluated the PChE activity in individuals 
exposed to arsenic via drinking water in Bangladesh.
Methods: A total of 141 Bangladeshi residents living in arsenic endemic areas with the mean arsenic exposure of 14.10 
± 3.27 years were selected as study subjects and split into tertile groups based on three water arsenic concentrations: 
low (< 129 μg/L), medium (130-264 μg/L) and high (> 265 μg/L). Study subjects were further sub-divided into two 
groups (≤50 μg/L and > 50 μg/L) based on the recommended upper limit of water arsenic concentration (50 μg/L) in 
Bangladesh. Blood samples were collected from the study subjects by venipuncture and arsenic concentrations in 
drinking water, hair and nail samples were measured by Inductively Coupled Plasma Mass Spectroscopy (ICP-MS). PChE 
activity was assayed by spectrophotometer.
Results: Arsenic concentrations in hair and nails were positively correlated with the arsenic levels in drinking water. 
Significant decreases in PChE activity were observed with increasing concentrations of arsenic in water, hair and nails. 
The average levels of PChE activity in low, medium and high arsenic exposure groups were also significantly different 
between each group. Lower levels of PChE activity were also observed in the > 50 μg/L group compared to the ≤50 
μg/L group. Moreover, PChE activity was significantly decreased in the skin (+) symptoms group compared to those 
without (-).
Conclusions: We found a significant inverse relationship between arsenic exposure and PChE activity in a human 
population in Bangladesh. This research demonstrates a novel exposure-response relationship between arsenic and 
PChE activity which may explain one of the biological mechanisms through which arsenic exerts its neuro-and 
hepatotoxicity in humans.
Background
Arsenic is a ubiquitous element present in food, soil,
water and airborne particles. The general population is
exposed to inorganic and organic arsenic through water,
food, occupation and other environmental sources. It has
been reported that a large section of the population in
Bangladesh and in West Bengal, India have been exposed
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to arsenic through arsenic contaminated drinking water
[1-3]. Bangladesh has already experienced the largest,
global catastrophe due to the presence of excessive
amounts of arsenic in drinking water [3]. A significant
number of toxicity cases have been already reported in
the north-west region in Bangladesh and approximately
16 million additional people are currently at risk for arse-
nic toxicity in the country. The situation is deteriorating
as the new cases of arsenic poisoning are still being
reported in different parts of the country. Although arse-
nic is a well established human carcinogen, paradoxically,
arsenic is also used to treat acute promyelocytic leukemia
(APL) due to its capacity to induce apoptosis in cancer
cells [4]. Due to its controversial medical status as both a
therapeutic treatment and as an acute toxigen, there are
renewed interests in exploring its potential benefits and
disadvantages. Arsenic in drinking water is typically inor-
ganic, and can be present either as As+3 (arsenite) or As+5
(arsenate). In Bangladesh, arsenic in ground water is pri-
marily in the As+3 form which is more toxic than the pen-
tavalent (As+5) form [5]. As+3 has higher affinity to thiol
groups of proteins and enzymes compared to the As+5 [6].
Most of the adverse effects of arsenic are caused by aber-
rant intracellular signalling pathways whereby arsenic
reacts with the thiol groups of proteins and enzymes and
changes their catalytic activity.
Arsenic toxicity induces dermatitis, multi-site cancers,
cardiovascular diseases, diabetes mellitus, immune disor-
ders, peripheral neuropathy, liver damage, renal failure,
and other illnesses [2,7-12]. Hepatic disorders including
hepatic cancer appear to be a primary cause of arsenic-
related mortality [13-15]. Previously Guha Mazumder
[16] conducted a study in an Indian population exposed
to arsenic and showed that prolonged drinking of arsenic
contaminated water was associated with hepatomegaly
characterized by increased activity of hepatic enzymes
that are used for liver function test. Oxidative DNA dam-
age, acquired tolerance to apoptosis, enhanced cell prolif-
eration, altered DNA methylation, genomic instability
and aberrant estrogen signaling [17,18] have been
reported in patients with liver toxicity caused by arsenic.
Neuropathy and neurological disorders are observed in
cases of both acute and chronic arsenic toxicity [19]. The
clinical features of neuropathy are paresthesias, numb-
ness and pain, particularly in the soles of the feet. Arse-
nic-induced neuropathy specifically is revealed by a
reduced nerve conduction velocity. Most of the adverse
effects of arsenic on nervous system are caused by inacti-
vated enzymes in the cellular energy pathway, whereby
arsenic reacts with the thiol groups of proteins and
enzymes and inhibits their catalytic activity. Further-
more, arsenic-induced neurotoxicity, like many other
neurodegenerative diseases, causes changes in cytoskele-
tal protein composition and hyperphosphorylation.
These changes may lead to disorganization of the
cytoskeletal framework, which is a potential mechanism
of arsenic-induced neurotoxicity.
True cholinesterase or acetyl cholinesterase is highly
specific for the neurotransmitter acetylcholine and cata-
lyzes the hydrolysis of acetylcholine into choline and ace-
tic acid, a reaction necessary to allow a cholinergic
neuron to return to its resting state after activation. Cho-
linesterase is a member of the serine hydrolase family,
which utilizes a serine residue at the active site [20].
Humans have three types of cholinesterase: red blood cell
(RBC) cholinesterase, called "true cholinesterase," plasma
cholinesterase, called "pseudo cholinesterase," and brain
cholinesterase. Acetylcholine causes the stimulation of
neurons while cholinesterase causes the ending of stimu-
lation by breaking down the acetylcholine. Cholinesterase
inhibiting chemicals cause breakdown of this balance,
leading to the development of neurotoxicity. Red blood
cell cholinesterase is the same enzyme that is found in the
nervous system, while the plasma cholinesterase also
known as butyryl cholinesterase is made in the liver.
Pseudo cholinesterase (PChE) has a broader range of
esterase activity that can hydrolyze butyryl choline, ace-
tylcholine and other aliphatic esters. Cholinesterase
activity was reported to be decreased in heart attack, liver
dysfunction, cancer metastasis [21], muscular tremors,
and neurological disorders. Decreased cholinesterase
activity is used to monitor the toxicity of some pesticides
such as organophosphate and carbamates that are associ-
ated with the development of liver diseases, peripheral
neuropathy, neuropsychiatric abnormalites and extra
pyramidal disorders [21-27].
Although PChE activity is used to monitor the liver
dysfunction and neurotxicity in humans exposed to sev-
eral toxic chemicals, the enzymatic activity has not yet
been evaluated clearly in the population chronically
exposed to arsenic. In this study, we therefore, assayed
the PChE activity in the human subjects exposed to arse-
nic to evaluate the relationship between arsenic exposure
and PChE activity.
Methods
Study areas
The selected study areas were chosen according to the
arsenic affected area map http://www.dchtrust.org/
arsenic_map.htm presented by the School of Environ-
mental Studies (SOES), Jadavpur University, India and
Dhaka Community Hospital, Bangladesh. Preliminary
information about the arseniasis-endemic areas was also
collected from the local health office. The study area
included Marua in Jessore, Dutpatila and Vultie in Chua-
danga and Bheramara in Kushtia district (north-west
region) of Bangladesh. Prevalence of typical skin symp-
toms of arsenicosis such as melanosis on the skin, hyper-Ali et al. Environmental Health 2010, 9:36
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keratosis and hard patches on the palms and soles were
very high in the local residents of these areas.
Ethical permission
Ethical permission for this study was approved by the
Bangladesh Medical Research Council, Mohakhali,
Dhaka-1212 (Ethical clearance no. BMRC/ERC/2007-
2010/558). All sorts of confidentialities and rights of the
study subjects were strictly maintained as per the guide-
line of the Bangladesh Medical Research Council.
Water collection and arsenic analysis
The drinking-water was entirely supplied by the tube
wells which were set up by the government or by individ-
uals. The tube well water was used for drinking, cooking
and other household purposes. We selected only those
tube wells that were being used by the local residents for
their drinking water. Water samples from these tube wells
were collected in acid-washed containers after the well
was pumped for five minutes as previously described
[28]. Total arsenic concentration in water samples was
determined by Inductively Coupled Plasma Mass Spec-
troscopy (ICP-MS, HP-4500, Agilent Technologies,
Kanagawa, Japan) after the addition of a solution of
yttrium (10 ppb in 1.0% nitric acid) to all water samples as
an internal standard for ICP-MS analysis. The ion signals
for arsenic and yttrium were monitored at m/z of 75 and
79, respectively. All samples were determined in triplicate
and the average values were used for data analysis. The
detection limit of As75 was 30 ppt. CRM, "river water"
(NMIJ CRM 7202-a No.347 National Institute of
Advanced Industrial Science and Technology, Japan) was
used as a certified reference material. The average value
(mean ± SD) of arsenic in the "river water" determined in
triplicate by ICP-MS analysis was 1.06 ± 0.04 μg/L (refer-
ence value, 1.18 μg/L).
Study subjects
Sequentially, drinking water sources (tube well water) in
the study areas and then study subjects who were drink-
ing water from those sources were selected. The study
subjects were selected without knowing their arsenic
exposure level in drinking water. The water from one
tube well is used either by the members of one family or
by the members of the several families. We recruited our
study subjects based on the largest possible number of
family members or families who used water from the
selected tube wells. Elderly persons (> 70 years of age),
pregnant women, lactating mothers, children (< 12 years
of age) and patients who underwent recent surgical oper-
ation were excluded from this study. The individuals, who
had previous and recent histories of drug addiction, hep-
atitis, hepatoxic drugs, malaria, and kalazar, and farmers
exposed to any kind of agricultural/home insecticides
within last one month, were also excluded as these could
influence PChE activity. Of the 153 individuals who were
approached, 141 were recruited (92.16% participation
rate) and 12 were excluded. We selected the study sub-
jects irrespective of symptoms; however, subjects with
skin symptoms were identified by a clinical doctor first
and then were further confirmed by a dermatologist. We
found that multiple members in one family suffered from
typical visible symptoms of arsenicosis such as melanosis
on the skin and hyperkeratosis and hard patches on the
palms and soles. The doctor involved in this study care-
fully checked many parts of the body for the confirmation
of the melanosis and hyperkeratosis.
Personal household interview
The subjects participated in this study gave their written
consent. Household visits were carried out to interview
residents. Personal interview of the study subjects was
carried out by our research team using a standard ques-
tionnaire. Information obtained from the interview
included the sources of water for drinking and daily
house hold uses, water consumption history, socioeco-
nomic status, occupation, food habit, cigarette smoking,
personal and family medical history, history of diseases,
physiological complications, major diseases, previous
physicians reports, Body Mass Index (BMI), recent his-
tory of agricultural and home insecticides or pesticides
exposure, uses of air fresheners, aerosol, mosquito coils,
and consumption of alcohol and tari (locally fermented
coconut palms).
Collection of nail and hair samples, and analysis of arsenic 
poisoning
Arsenic levels in nail and hair samples have been
reported to provide the integrated measures for arsenic
exposure [29,30]. Nail samples were collected from each
study subject as described previously [31]. Hair samples
with the length of about 1 cm were collected from the
region of the head close to the scalp behind the ear by
using a ceramic blade cutter and kept in polypropylene
bottles [32]. Nail and hair samples were cleaned by the
method described by Chen et al. [33]. Briefly, samples
were immersed in 1% Triton X-100, sonicated for 20 min-
utes, and then washed five times with milli-Q water. The
washed samples were allowed to dry at 60°C overnight in
a drying oven. Nail and hair samples were digested with
concentrated nitric acid using a hot plate at 70°C for 15
minutes and 115°C for 15 minutes. After cooling, the
samples were diluted with 1.0% nitric acid containing
yttrium (10 ppb), and concentrations of As75 and Y79 in
these samples were determined by ICP-MS. Determina-
tion of the accurate arsenic concentrations in these bio-
logical materials was verified by using a CRM "cod fish
powder" (NMIJ CRM 7402-a, National Institute ofAli et al. Environmental Health 2010, 9:36
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Advanced Industrial Science and Technology, Japan). The
average value (mean ± SD) of arsenic in "cod fish powder"
determined in triplicate by the above-mentioned diges-
tion followed by ICP-MS analysis was 34.9 ± 2.35 μg/g
(reference value, 36.7 μg/g).
Collection of blood plasma
All study subjects were requested to gather in a conve-
nient nearby locality. Fasting blood samples were col-
lected from the study subjects. Blood samples (5-7 ml)
were collected from each individual by venipuncture in
the EDTA-containing blood collection tubes. Whole
blood was then placed immediately on ice and subse-
quently centrifuged at 1,600 × g for 15 minutes at 4°C.
Plasma supernatant was then taken and stored at -80°C.
Laboratory examination
PChE activity was measured using butyryl cholinesterase
(CHE) kit according to the manufacture's protocol (RAN-
DOX, UK). The principle of colorimetric method is
briefly described below: Butyryl cholinesterase hydroly-
ses butyrylthiocholine to give thiocholine and butyrate.
The reaction between thiocholine and dithiobis
(nitrobenzoate) gives 2-nitro-5-mercaptobenzoate, a yel-
low compound which can be measured at 405 nm
(Microlab 200, Vital Scientific, Dieren, Netherlands). All
human samples were analyzed in triplicate, and then
mean values were taken.
Statistical analysis
Statistical analysis for this study was performed by
using software of Statistical Packages for Social Sciences
(SPSS). The study subjects were split into tertile groups
based on drinking water arsenic concentrations of equal
proportions based on frequency testing: low (< 129 μg/L),
medium (130-264 μg/L) and high (> 265 μg/L). We per-
formed Spearman correlation coefficient test to evaluate
the correlation of water arsenic with hair or nail arsenic
in low, medium and high exposure groups; the correla-
tion of water arsenic concentrations with hair or nail
arsenic concentrations and to evaluate the association
between PChE activity and the concentration of arsenic
in water or hair or nails. PChE activity in low, medium
and high exposure groups was evaluated by one way
ANOVA. PChE activity between the groups based on the
regulatory upper limit of arsenic concentration in drink-
ing water in Bangladesh and on the prevalence of skin
s y m p t o m s  w e r e  a n a l y z e d  b y  I n d e p e n d e n t  S a m p l e s  T -
Test. Effects of age, sex, arsenic concentration in water
and BMI were analyzed by main effect model (four-way
classification).
Results
General characteristics of the study subjects
Table 1 shows the characteristics of the study subjects in
the low, medium and high exposure groups depending on
the water arsenic concentrations. There were total 52
female and 89 male subjects with a mean age of 37.66 ±
12.51 years. Most of the female study subjects were house
wives (90.70%) and the remaining 9.30% were farm work-
ers, tailors or other professions. Most of the male subjects
were farmers (85.54%) and remaining 14.46% were small
vendors, rickshaw puller or other professions. The aver-
age duration of chronic arsenic exposure for all study
subjects was 14.10 ± 3.27 years. The mean concentrations
of water arsenic in the low, medium and high groups were
32.13 ± 43.55, 215.82 ± 36.96 and 426.80 ± 91.10 μg/L,
respectively. It has been confirmed by questionnaire that
the study subjects were not exposed to any kind of agri-
cultural/home insecticides or pesticides at least for the
last month. The mean BMI of the low, medium and high
arsenic exposure groups were within normal range: 20.89
± 3.24, 20.32 ± 3.08 and 20.11 ± 3.35, respectively.
Approximately 70% of the study subjects showed typical
symptoms of arsenicosis such as diffused or spotted mel-
anosis or hyperkeratosis on the skin, foot and palms.
Hair and nail arsenic concentrations in low, medium and 
high exposure groups
Table 2 shows the hair and nail arsenic concentrations in
low (< 129 μg/L), medium (130-264 μg/L) and high (> 265
μg/L) arsenic exposure groups. Arsenic concentrations in
water showed significant positive correlations with arse-
nic concentrations in hair and nails in each of three
groups and also in all subjects.
Correlations of water arsenic concentrations to arsenic 
concentrations in hair and nails
Water arsenic concentrations showed positive dose-
dependent relationship (rs = 0.62, p  < 0.001) with hair
arsenic concentrations (Figure 1A). Similarly, a positive
relationship (rs = 0.64, p < 0.001) was observed between
water and nail arsenic concentrations (Figure 1B).
PChE activity and arsenic exposure
Figure 2 shows the effect of arsenic exposure on PChE
activity. A significant decrease in PChE activity was
observed with the increasing concentrations of arsenic in
drinking water (Figure 2A) with a significant negative
correlation (rs = -0.52, p < 0.001). A similar relationship
was observed between PChE activity and hair arsenic
concentrations (rs = -0.47, p  < 0.001, Figure 2B), and
between PChE activity and nail arsenic concentrations (rs
= -0.35, p < 0.001, Figure 2C). The level of PChE activity
was found to be significantly decreased in medium versus
low (p < 0.01), high versus medium (p < 0.01) and high
versus low (p < 0.001) arsenic exposure groups (Figure 3).
Furthermore, we divided the study subjects into two
groups (Table 3) based on the recommended upper limit
(50 μg/L) of arsenic concentration in water for Bangla-
desh, and found that PChE activity was significantly (pAli et al. Environmental Health 2010, 9:36
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<0.001) lower in the > 50 μg/L group than in the ≤50 μg/L
group. Usually skin symptoms such as melanosis on the
skin, hyperkeratosis and hard patches on the palms and
soles are developed as a result of prolonged exposure of
arsenic. The majority of our study subjects (approxi-
mately 70%) had typical skin symptoms of arsenicosis.
Therefore, we next compared the PChE activity based on
the presence of skin symptoms (Table 3). We categorized
the study subjects into two groups of with (+) and with-
out (-) symptoms. Intriguingly, PChE activity was signifi-
cantly decreased in the skin (+) symptoms group
compared to the without (-) symptoms group.
Effects of age, sex, water arsenic and BMI on PChE activity
We checked the effects of confounders (age, sex, water
arsenic concentration and BMI) on PChE activity. Results
from the main effect model (four-way classification)
showed that there were no significant effects of age, sex
and BMI on PChE activity (Table 4). On the other hand, a
clear significant association (p < 0.001) between PChE
activity and water arsenic concentrations was observed.
The main effect model controlled for age, sex, water arse-
nic levels and BMI.
Discussion
In this study, we assayed the PChE activity in the popula-
tion of the severely arsenic-contaminated areas in the
north-west region of Bangladesh. The decreased activity
of cholinesterase was reported previously in rats that
were injected with high doses of arsenic only for five days
[34]. The arsenic-mediated decrease in cholinesterase
activity in an animal model prompted us to examine the
status of this enzyme in a human population that was
exposed to arsenic. We found that hair and nail arsenic
concentrations were positively correlated with the arsenic
concentrations in drinking water (Figure 1). These results
were in agreement with the previous report [35], which
suggested that arsenic content of hair and nail samples
might be used as an effective biomarker of arsenic intake.
PChE activity in this population was decreased with
increasing levels of arsenic in the drinking water (Figure
2A). Similar effects were also observed with the increas-
ing levels of arsenic in hair and nails (Figure 2B and 2C,
respectively). Consistent results across these three expo-
sure metrics explicitly stated the potential role of chronic
arsenic exposure in lowering PChE activity in humans.
We further examined the PChE activity splitting the
Table 1: General characteristics of the study subjects based on water arsenic
Characteristics All Subjects Low
(< 129 μg/L)
Medium
(130 - 264 μg/L)
High
(> 265 μg/L)
No. of subject 141 44 50 47
Sex
[no. (male/female)]
89/52 32/12 32/18 25/22
Age
[years (Mean ± SD)]
37.66 ± 12.51 39.34 ± 13.71 35.22 ± 10.93 38.43 ± 12.90
Water arsenic concentration
[μg/L (Mean ± SD)]
224.92 ± 57.20 32.13 ± 43.55 215.82 ± 36.96 426.80 ± 91.10
Water consumption (L/day) 2.30 ± 1.09 1.71 ± 1.01 2.54 ± 1.13 2.65 ± 1.15
Years of arsenic exposure (Mean ± SD) 14.10 ± 3.27 16.00 ± 3.10 13.20 ± 3.20 13.10 ± 3.50
Occupation
Female 90.70 87.34 90.21 94.54
Housewives (%) 9.30 12.66 9.79 5.46
Others (%) [Farmworkers, tailors etc.]
Male
Farmers (%) 85.54 85.26 87.45 83.91
Others (%) [Venders, rickshaw pullers etc.] 14.46 14.74 12.55 16.09
(+) symptomps [% (Melanosis and hyperkeratosis)] 69.52 61.37 60 87.2
(-) symptomps (%) 30.48 38.63 40 12.8
BMI* 20.44 ± 3.22 20.89 ± 3.24 20.32 ± 3.08 20.11 ± 3.35
BMI* was calculated as body weight (kg) divided by square body height (m2)
Frequency test is used to divide the study subjects into three groups of equal proportion based on water arsenic concentrationAli et al. Environmental Health 2010, 9:36
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study subjects into tertile groups based on water arsenic
levels. Interestingly, a lower level of PChE activity was
observed in higher tertile groups (Figure 3). Since a previ-
ous study indicated that males were more vulnerable to
arsenic toxicity than females [36], we examined the
effects of confounding factors such as age, sex and BMI
on PChE activity. However, no significant effect of these
factors was detected (Table 4). Therefore, all these results
provided important evidence to conclude that arsenic
exposure could be an important contributor for lowering
PChE activity in humans.
While this manuscript was under preparation, Hernan-
dez's et al. [37] reported that the activity of cholinesterase
was not decreased by arsenic. The reasons for this dis-
crepancy may be attributable to the differences in study
population and levels of arsenic exposure between the
two studies. Hernandez's group did not examine the
effect of arsenic in drinking water. They selected healthy
population from Spain who had much lower levels of
arsenic in urine. Whereas, in our study subjects, the
exposures occurred for much longer periods of time and
were in much higher levels resulting in a visible dermal
toxicity in the majority (approximately 70%) of the popu-
lation. Thus, it is possible that the arsenic-mediated
decrease in PChE activity may be limited to a population
who are chronically exposed to high level of arsenic from
contaminated drinking water. This notion is supported by
a report of an animal model experiment that showed an
inverse relationship between high level of arsenic and
cholinesterase activity [34]. Further studies are needed to
examine whether the PChE activity decreases or not at
lower exposures for prolonged periods of time.
Decreased PChE activity has also been reported earlier
to be associated with the exposure of the pesticides such
as organophosphate and carbamates [22]. To avoid the
involvement of confounding effects such as exposure to
insecticides or pesticides, we confirmed, prior to the
sample collection, that our study subjects did not use any
kind of agricultural/home insecticides or pesticides for
no less than the past month. Many of our study subjects
for the most part were uneducated about the general dan-
gers related to exposure to home insecticides and/or pes-
ticides. This population belonging to Bangladesh's low
socio-economic group were unfamiliar with the use of
mosquito coils, aerosol, air fresheners, etc. in their daily
lives for protection. Prior to sample collection, we
explained to them about some home insecticides and
asked them to provide us with information regarding
their past and present exposure to these types of insecti-
cides. In addition, we performed an alternative experi-
ment selecting some subjects (n = 22) from the city (non-
agricultural region) where the possibilities of drinking
water pollution by pesticides or insecticides were very
low. The levels of arsenic in the drinking water for these
subjects had not crossed the maximum permissive limit
and accordingly, the hair and nail arsenic levels were also
low. We observed that the PChE activity of this group was
almost the same compared to that of the lower arsenic
exposure group of the study subject in arseniasis-
endemic areas (unpublished results). These results main-
t a i n  t h a t  t h e  p o s s i b l e  r o l e  o f  c o n f o u n d e r s  ( p e s t i c i d e s /
insecticides) on PChE activity in this study might be very
low or negligible. Nevertheless, we can not exclude the
Table 2: Hair & nail arsenic concentrations and their correlations with water arsenic concentrations
Water arsenic exposure n Hair arsenic concentration Nail arsenic concentration
[μg/g (Mean ± SD)] Spearman r [μg/g (Mean ± SD)] Spearman r
Low (< 129) 44 1.83 ± 3.00 0.413** 3.51 ± 4.41 0.421**
Medium (130-264) 50 4.08 ± 2.60 0.489** 6.32 ± 5.62 0.384*
High (> 265) 47 9.74 ± 10.13 0.464** 12.51 ± 9.13 0.499***
All subjects 141 5.27 ± 7.06 0.524*** 7.51 ± 7.64 0.541***
Here *p < 0.05, **p < 0.01 and ***p < 0.001 are from Spearman correlation coefficient test
Figure 1 Dose-related relationship of water arsenic with hair and 
nail arsenic concentrations. Relationship between drinking water ar-
senic and the arsenic in hair (A) or in nails (B) of the study subjects. Ar-
senic concentrations in water, hair and nails were used after log 
transformation. rs and p- values are from Spearman correlation coeffi-
cient test.
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possibility that the effects of some chemicals are involved
in the decrease in PChE activity in our study subjects.
However, if another accompanying chemical agent in
drinking water could also be responsible for the observed
association between arsenic and PChE activity, the chem-
ical would follow the same concentration gradient as
arsenic in the drinking water. This is unlikely, but more
detailed examination of the chemical components in
drinking water may be required in a future study.
The mechanisms for how arsenic decreases cholinest-
erase activity have not yet been documented. Arsenic
compounds are known as potent inhibitor of many
enzymes [38] and the reaction between the arsenic and
the free sulfhydryl groups of enzymes may underlie the
mechanism of this inhibition. However, cholinesterase
does not have the structural features suitable for binding
with arsenic. Cholinesterase has been found to contain
cysteine only in the form of disulphide bridges and not as
free thiol [39]. Moreover, other reactant chemicals in the
sulfhydryl group such as iodoacetamide or mercury com-
pounds did not inhibit cholinesterase [40]. Therefore,
arsenic reduces the activity of cholinesterase probably
due to other mechanisms rather than the direct binding
to the enzyme.
Cholinesterase is considered to be a clinically impor-
tant enzyme because it is involved in both liver function
abnormalities and neurotoxicity by several toxic chemi-
cals. Despite the deleterious action of arsenic on liver and
central nervous system, there have been very limited
studies of the effect of arsenic on liver and nervous sys-
tem. Therefore, the present study provided new insights
into liver function abnormalities and neurotoxicity
caused by arsenic. We have also a future plan to conduct a
follow up study to investigate the level of PChE activity in
our study subjects. Many of them have already obtained
opportunities for drinking relatively safe water containing
Table 3: PChE activity in the groups based on the skin symptoms and on the regulatory upper limit of arsenic 
concentration (50 μg/L) in drinking water
Parameters Categories n PChE activity (U/L) × 104 (Mean ± SD) p-value
Skin symptoms (-) Symptoms 43 1.693 ± 0.394 0.000
(+) Symptoms 98 1.359 ± 0.349
Arsenic in drinking water ≤ 50 μg/L 33 1.775 ± 0.371 0.000
> 50 μg/L 108 1.365 ± 0.349
p-values are from Independent Samples T-Test
Figure 2 Effect of arsenic exposure on PChE activity. Effects of 
drinking water (A), hair (B) and nail (C) arsenic concentrations on PChE 
activity. Arsenic concentrations were used after log transformation. rs 
and p- values are from Spearman correlation coefficient test.
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reduced levels of arsenic provided by the several govern-
ment and non-governmental organizations in the arse-
niasis-endemic areas in Bangladesh. Reduced levels of
arsenic concentration in water are expected to increase
the PChE activity to its normal level and decrease the risk
of arsenic-induced pathogenesis.
Conclusions
In this study, we found that hair and nail arsenic concen-
trations were positively correlated with arsenic concen-
trations in drinking water in a human population exposed
to arsenic in Bangladesh. A significant inverse relation-
ship between arsenic exposure and PChE activity was
observed. Thus, this research demonstrates a novel expo-
sure-response relationship between arsenic and PChE
activity which may explain one of the biological mecha-
nisms through which arsenic exerts its neuro-and hepato-
toxicity in humans.
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